Thursday, Jun 04, 2020 | Last Update : 07:08 PM IST

72nd Day Of Lockdown

Maharashtra74860323292587 Tamil Nadu2587214316208 Delhi236459542615 Gujarat18117122121122 Rajasthan96526744209 Uttar Pradesh88705257230 Madhya Pradesh82835003358 West Bengal61682410364 Karnataka4063151453 Andhra Pradesh3971246468 Bihar3945174123 Telangana3020155699 Jammu and Kashmir260194631 Odisha238814169 Haryana2356105521 Punjab2301200044 Kerala149565112 Assam14862854 Uttarakhand9592225 Jharkhand6612965 Chhatisgarh5481211 Tripura4231730 Himachal Pradesh3401186 Chandigarh2972144 Puducherry88300 Manipur83110 Goa73500 Nagaland5800 Arunachal Pradesh3710 Meghalaya33131 Mizoram1410 Sikkim200

Signs of hope: Cell biologists report discovery of first antibody to combat Covid-19

THE ASIAN AGE. | B R SRIKANTH
Published : Mar 16, 2020, 7:48 pm IST
Updated : Mar 16, 2020, 7:49 pm IST

Team of 10 researchers say: “In conclusion, this is the first report on a (human) monoclonal antibody that neutralizes SARS CoV-2.

Cell biologist Prof Frank Grosveld, one of the members of the research team.
 Cell biologist Prof Frank Grosveld, one of the members of the research team.

Bengaluru: In a sign of hope since the outbreak of the COVID-19 pandemic, ten biologists working at Utrecht University in the Netherlands have reported the discovery of the first antibody that can aid the detection and prevention of infection by SARS2, the coronavirus.

The team tested this antibody (which is a protein produced by the host body in response to antigens such as viruses) successfully on mice, and announced the breakthrough in their paper, titled ‘A human monoclonal antibody blocking SARS-CoV-2’, posted on BioRxiv, a website where biologists publish about their research projects. 

At the end of a detailed explanation, the biologists state: “In conclusion, this is the first report on a (human) monoclonal antibody that neutralizes SARS CoV-2.”

Interestingly, the antibody was isolated before the pandemic.

The scientists found that it cross-reacts (the biological term for repelling a foreign substance) and thus prevents the virus from being able to infect. This discovery also helps in the detection of the virus.

The Utrect University team had joined a European project titled ZAPI (Zoonoses Anticipation and Preparedness Initiative) with an intention to develop antibodies against the MERS (Middle East Respiratory Syndrome), SARS (Severe Acute Respiratory Syndrome) and the Hong Kong coronavirus (OC-43).

However, they retained in their refrigerator untested antibodies from a previous study that did not react with all three mutations, but did so with SARS1. When the current crisis – SARS2 – broke out, the team tested whether the antibodies that reacted with SARS1 also responded to SARS2, and thus discovered the antibody.

The biologists were ahead of other researchers working on coronavirus antibodies thanks to their earlier work on developing antibodies for other viruses. 

The next task on hand for this team is to identify a pharmaceutical company to produce the antibody on a large scale as a cure for COVID-19, develop a diagnostic test kit, and produce a vaccine against the virus. 

The first three joint authors of the paper are Dr Chunyan Wanga, Dr Wentao Lia, and Dr Dubravka Drabekb, while the other senior authors of the paper are Prof Frank Grosveld and Prof Berend-Jan Boscha.

Tags: utrecht university, cvid-19, coronavirus, pandemic, biorxiv, sars cov-2
ADVERTISEMENT
ADVERTISEMENT